Cargando…
The oncogenic role of MUC12 in RCC progression depends on c‐Jun/TGF‐β signalling
Renal cell carcinoma (RCC) is a common kidney cancer worldwide. Even though current treatments show promising therapeutic effectiveness, metastatic RCC still has limited therapeutic options so that novel treatments were urgently needed. Here, we identified that MUC12 was overexpressed in RCC patient...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412406/ https://www.ncbi.nlm.nih.gov/pubmed/32596961 http://dx.doi.org/10.1111/jcmm.15515 |